pertussis vaccine
First Pertussis Vaccine Dose and Prevention of Infant Mortality
12
Pertussis Vaccine Effectiveness in the Setting of Pertactin-Deficient Pertussis
12
The Relationship Between Pertussis Vaccine and Brain Damage: Reassessment
6
When Is There Enough Evidence to Stop Worrying About Pertussis Vaccine?
6
Strain Variation among Bordetella pertussis Isolates in Finland, Where the Whole Cell Pertussis Vaccine Has Been Used for 50 Years
7
Pertussis Vaccine
5
ENCEPHALOPATHIES FOLLOWING PROPHYLACTIC PERTUSSIS VACCINE
23
Synergic Effect of Genotype Changes in Pertussis Toxin and Pertactin on Adaptation to an Acellular Pertussis Vaccine in the Murine Intranasal Challenge Model
6
Epidemic Pertussis and Acellular Pertussis Vaccine Failure in the 21st Century
5
Strain Variation among Bordetella pertussis Isolates Circulating in Poland after 50 Years of Whole Cell Pertussis Vaccine Use
6
Acellular Pertussis Vaccine Effectiveness Over Time
11
Cost of Management of Adverse Events of Pertussis Vaccine
10
Adverse Reactions and Serologic Response to a Booster Dose of Acellular Pertussis Vaccine in Children Immunized With Acellular or Whole-Cell Vaccine as Infants
8
Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
8
Immune Responses to Pertussis Antigens in Infants and Toddlers after Immunization with Multicomponent Acellular Pertussis Vaccine
7
Evaluation of the Pertussis Components of Diphtheria-Tetanus-Pertussis Vaccine
8
Hypotonic–Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996–1998
11
Toxic Effects of Indoor Molds
6
Read This—It's Important
6
The Recommended Childhood Immunization Schedule of the United States
5